logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Saint Noah Pharmaceuticals-B (02257.HK): Ouyang Yunlong appointed as non-executive director.

date
03/07/2025
Wisdom Finance and Economics APP News, SanNuo Pharmaceuticals-B(02257.HK) announced that Mr. Ouyang Yunlong has been appointed as a non-executive director, effective from July 3, 2025.
Latest
3 m ago
Soton Development (603612.SH) shareholders plan to collectively reduce their holdings by no more than 2.21% of the shares.
3 m ago
Fuhong Hanlin: Awarded two EU GMP certificates
3 m ago
On July 3, Fuhong Hanlin announced on the Hong Kong Stock Exchange that its wholly-owned subsidiary Shanghai Fuhong Hanlin Biopharmaceutical Co., Ltd. has received two GMP certificates from the Federal Agency for Medicines and Health Products in Belgium for the production of HLX11 (DS) raw material, formulation (DP) production line, and packaging production line, as well as for the production of HLX14 (DS) raw material, formulation (DP) line 2, formulation (DP) line 3, and packaging production line. This GMP certification indicates that the HLX11 and HLX14 production lines have met the EU GMP standards under the EU GMP mutual recognition system among EU Member States.
4 m ago
Zhongwei Corporation (300919.SZ) intends to reduce its holdings by no more than 201,900 shares.
4 m ago
Yukai Development: It is expected that the net profit will increase by 632%-784% in the first half of 2025 compared to the same period.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.